Renal ColicERRCNCT06982430
Early Recurrence of Renal Colic: Predictive Factors
An observational study of Renal Colic, run by University of Monastir at 1 site in Tunisia.
Trial summary
Renal colic (RC) is a common pathology in emergency medicine, with a high risk of recurrence. Early recurrence remains a major concern, affecting up to 30% of patients, with around 84% of these recurrences occurring within two days of the initial episode , despite preventive measures, both pharmacological and… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Renal Colic
- What is being tested?
- phone call
- How many people
- 878 participants
- Where
- 1 siteTunisia
- Study dates
- 1 Jan 2022to 31 May 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: included patients over 18 years of age who were admitted to the ED for acute abdominopelvic pain and whose final diagnosis was RC
Who may be able to join
- patients over 18 years of age who were admitted to the ED for acute abdominopelvic pain and whose final diagnosis was RC
Who cannot join
- patients with documented or suspected pregnancy, and patients without a phone number
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Identification of Predictive Factors for Early Recurrence of Renal Colic Pain After Emergency Department Treatment: A Prospective Study
Renal colic (RC) is a common pathology in emergency medicine, with a high risk of recurrence. Early recurrence remains a major concern, affecting up to 30% of patients, with around 84% of these recurrences occurring within two days of the initial episode , despite preventive measures, both pharmacological and non-pharmacological . The recurrence of RC varies significantly between individuals, and systematic evaluation may facilitate personalized treatment . Recurrence is likely influenced by multiple factors, and identifying these could help clinicians develop better preventive strategies.The main aim of our study was to identify factors predictive of early recurrence of RC pain after emergency department (ED) management.
- Conditions
- Renal Colic
- Being tested
- phone call
- Keywords
- Early recurrence, Renal colic pain, emergency department
- Medical subject headings
- Renal Colic, Recurrence, Emergencies
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
phone callOther
Included patients were evaluated on day 7 after discharge from the ED through a telephone call.
This evaluation aimed to identify a recurrence of RC, defined as a NRS score greater than 3 within the 7 days following inclusion and/or a return visit for the same complaint
| Study group | Role | What they receive |
|---|---|---|
| prospective study of 878 patients | Not described Receives: Other: phone call |
What is being measured
The primary outcome is the main question the study is designed to answer.
RC recurrence
NRS score greater than 3 within the 7 days following inclusion and/or a return visit for the same complaint
Measured: 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 May 2025
- Study start1 Jan 2022
- Primary completion31 May 2024
- Study completion31 May 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Renal ColicStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 878 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Monastir
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Pr. Semir Nouira, University of Monastir
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06982430
- Sponsor's protocol ID
- ERRC
- Acronym
- ERRC
- Status last verified
- Jan 2022
- First submitted
- 13 May 2025
- Last updated
- 19 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Identification of Predictive Factors for Early Recurrence of Renal Colic Pain After Emergency Department Treatment: A Prospective Study
- ClinicalTrials.gov ID
- NCT06982430
- Acronym / sponsor ID
- ERRC / ERRC
- Conditions
- Renal Colic
- Keywords
- Early recurrence, Renal colic pain, emergency department
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 878 participants (actual)
- Lead sponsor
- University of MonastirUniversity, hospital or other
- Study start
- 1 Jan 2022 (actual)
- Primary completion
- 31 May 2024 (actual)
- Study completion
- 31 May 2024 (actual)
- First posted
- 21 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Renal colic (RC) is a common pathology in emergency medicine, with a high risk of recurrence. Early recurrence remains a major concern, affecting up to 30% of patients, with around 84% of these recurrences occurring within two days of the initial episode , despite preventive measures, both pharmacological and non-pharmacological . The recurrence of RC varies significantly between individuals, and systematic evaluation may facilitate personalized treatment . Recurrence is likely influenced by multiple factors, and identifying these could help clinicians develop better preventive strategies.The main aim of our study was to identify factors predictive of early recurrence of RC pain after emergency department (ED) management.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| prospective study of 878 patients | – | Other: phone call |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- included patients over 18 years of age who were admitted to the ED for acute abdominopelvic pain and whose final diagnosis was RC
Key inclusion criteria (1 listed)
- patients over 18 years of age who were admitted to the ED for acute abdominopelvic pain and whose final diagnosis was RC
Key exclusion criteria (1 listed)
- patients with documented or suspected pregnancy, and patients without a phone number
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| phone callIncluded patients were evaluated on day 7 after discharge from the ED through a telephone call. This evaluation aimed to identify a recurrence of RC, defined as a NRS score greater than 3 within the 7 days following inclusion and/or a return visit for the same complaint | Other | prospective study of 878 patients |
Primary outcome
RC recurrence
Time frame: 7 days
NRS score greater than 3 within the 7 days following inclusion and/or a return visit for the same complaint
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2026.
Related trials for Renal Colic
RecruitingPhase 3
Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the ED
Renal Colic
Not yet recruiting
Relief Efficacy of Lidocaine Versus Morphine for Acute Renal Colic in the Emergency Department
Renal Colic, Kidney Stones, Urolithiasis, Hypocitraturia
Recruiting
Ear Pressure Points Plus Pain Meds for Faster Kidney Stone Pain Relief
Renal Colic, Acupuncture, Ear
Active, not recruiting
Sterile Water Injection vs Morphine for Renal Colic
Renal Colic, Urolithiasis
Not yet recruitingPhase 4
Analgesic Efficacy of Transcutaneous Electrical Nerve Stimulation and Dexketoprofen in Renal Colic
Renal Colic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Renal Colic, run by University of Monastir at 1 site in Tunisia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Tunisia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
RC recurrence (time frame: 7 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.